Seeking growth in the stagnant US chewing gum market, 109-year-old major player Wm. Wrigley Jr. Co. is embarking on its first medicinal-gum venture with Surpass.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


Containing antacids, Surpass is intended to take Wrigley into the profitable pharmaceutical aisle, where other gums containing aspirin or antacids already exist. The market is large enough for the producers to co-exist however, and Wrigley has now formed a health care division with the intention of exploring other possibilities for medicinal gum.


Wrigley has also posted revenue of US$2.15bn for 2000, up 4.4% from the previous year. Earnings rose 6.7% on 1999, reaching US$328.9m.

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now